NuView Radiopharmaceuticals will act as exclusive agent for Positron’s brand of Pet, Spect and automated dose dispensing systems.
Paul Crowe, CEO of NuView, said: “We’re very pleased to have been selected by Positron to represent their automated dose drawing, Spect and Pet diagnostic imaging technologies in the US. The Pet devices small footprint makes it the ideal system for private offices or clinic settings.”